GEODE-II: Efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir with low-dose ribavirin QD in patients with genotype 1a chronic hepatitis C virus infection without cirrhosis

Authors
Category Primary study
JournalHepatology
Year 2016
This article has no abstract
Epistemonikos ID: 71b1e77b70e0a8c5475801b2b6e93ff95ab1a8ca
First added on: Feb 08, 2025